Waters Corp Subsidiary Prices $3.5 Billion Senior Notes to Fund Acquisition
Summary
Waters Corp's subsidiary, Augusta SpinCo, priced a $3.5 billion senior notes offering, a key financing component for the recently completed $16.8 billion acquisition of BD's Biosciences & Diagnostic Solutions.
Key Events
-
Finalizes $3.5 Billion Senior Notes Offering
Augusta SpinCo Corporation, a subsidiary of Waters Corp, priced $3.5 billion in senior notes across five tranches with maturities ranging from 2027 to 2036 and coupons from 4.321% to 5.245%.
-
Supports Major Acquisition Financing
This debt offering is a critical component in financing Waters Corp's recently completed $16.8 billion acquisition of BD's Biosciences & Diagnostic Solutions business.
-
Investment Grade Rating Achieved
The senior notes received investment-grade ratings of Baa2/BBB (Stable/Stable), reflecting the company's credit quality.
Analysis
This Free Writing Prospectus finalizes the terms for Augusta SpinCo Corporation's offering of $3.5 billion in senior notes across five tranches. This significant debt issuance, rated investment grade (Baa2/BBB), is a crucial step in financing Waters Corp's recently closed $16.8 billion acquisition of BD's Biosciences & Diagnostic Solutions business, as previously disclosed in the 8-K filing on March 16, 2026. The successful pricing of this substantial debt package provides the necessary capital to support the strategic acquisition.
At the time of this filing, WAT was trading at $296.99 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $29.1B. The 52-week trading range was $275.05 to $414.15. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.